EDTA chelation therapy has been available since the 1950s. When EthyleneDiamineTetraacetic Acid is injected intravenously, it circulates through the bloodstream and binds to or chelates metal ions pulled from tissues so they can be flushed from the body. Physicians use EDTA chelation to treat lead poisoning. It has also been used to remove aluminum, arsenic, copper and mercury.
Some doctors have used EDTA to remove calcium in the hopes of improving circulation and reducing the risk of heart disease. Most cardiologists have dismissed this therapy on the grounds that there are no data to support its use.
Last spring, however, a study published in the Journal of the American Medical Association showed a benefit in high-risk heart patients. Now a follow-up analysis of this 10-year study reveals that EDTA chelation reduces heart attacks, strokes and death from heart disease by 40 percent in people with diabetes. The placebo-controlled trial was paid for with taxpayer funding. Although it contradicts conventional cardiology wisdom, it seems that it is time to start paying attention to chelation.
[American Heart Association meeting, Dallas, Nov. 19, 2013]
